Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Inspirna, Inc.
Condition: Colorectal Cancer, Metastatic Colon Cancer
NCT05983367
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
At the time of the primary analysis, results did not meet the primary endpoint